Fowler Paul A, Spears Norah
The Department of Obstetrics and Gynaecology, University of Aberdeen, Aberdeen, UK.
Reproduction. 2004 Jun;127(6):679-88. doi: 10.1530/rep.1.00141.
Gonadotrophin surge-attenuating factor (GnSAF) bioactivity (the suppression of GnRH-induced but not basal LH and FSH secretion from pituitary gonadotrophs) is produced by granulosa cells in vitro. Previous studies to investigate this bioactivity used dispersed granulosa cells which lack some cell types and the structural components of the follicle in vivo. The aim of this study, therefore, was to investigate whether intact rodent follicle culture was a suitable model for the study of the production of GnSAF bioactivity, allowing GnSAF to be investigated in a more physiologically realistic environment while still retaining culture conditions from which, as with granulosa cell cultures, extraneous factors can be excluded. Follicles from 16-day-old rats and 21-day-old mice were cultured for 3-6 days in the presence or absence of FSH and/or LH. The follicle-conditioned medium, and matching samples of unconditioned culture medium were added to our established rat pituitary monolayer GnSAF bioassay. Both mouse and rat intact follicles produced GnSAF bioactivity, reducing GnRH-induced LH secretion significantly. GnSAF output from the mouse follicles was highest during days 1-3 of culture, when follicles were at an early antral stage of development, and fell on days 4-6 as the follicles grew to the mid antral stage. While the stimulatory effects of FSH on rat follicle GnSAF secretion was dose-dependent, LH alone did not increase GnSAF production. An antibody against human GnSAF blocked GnSAF bioactivity produced by rat follicles, and recognised proteins within the expected pI and molecular weight range for GnSAF in two-dimensional gels of rat follicle-conditioned medium, showing a good homology between rodent and human GnSAF proteins. In conclusion, the release of GnSAF bioactivity is principally from small follicles stimulated by FSH. Therefore, intact rodent follicle culture systems offer an excellent model for the investigation of factors controlling GnSAF production under relatively physiological conditions.
促性腺激素激增衰减因子(GnSAF)的生物活性(抑制垂体促性腺细胞中促性腺激素释放激素(GnRH)诱导的促黄体生成素(LH)和促卵泡生成素(FSH)分泌,但不抑制基础分泌)在体外由颗粒细胞产生。以往研究该生物活性时使用的是分散的颗粒细胞,这些细胞缺乏体内卵泡的某些细胞类型和结构成分。因此,本研究的目的是探讨完整的啮齿动物卵泡培养是否是研究GnSAF生物活性产生的合适模型,使GnSAF能够在更符合生理实际的环境中进行研究,同时仍保留与颗粒细胞培养一样能够排除外部因素的培养条件。将16日龄大鼠和21日龄小鼠的卵泡在有或无促卵泡生成素(FSH)和/或促黄体生成素(LH)的情况下培养3 - 6天。将卵泡条件培养基以及相应的未条件培养基样本加入我们已建立的大鼠垂体单层GnSAF生物测定中。小鼠和大鼠的完整卵泡均产生GnSAF生物活性,显著降低GnRH诱导的LH分泌。小鼠卵泡的GnSAF产量在培养的第1 - 3天最高,此时卵泡处于早期卵泡腔阶段,随着卵泡生长至卵泡腔中期,在第4 - 6天下降。虽然FSH对大鼠卵泡GnSAF分泌的刺激作用呈剂量依赖性,但单独使用LH并不会增加GnSAF的产生。一种抗人GnSAF抗体可阻断大鼠卵泡产生的GnSAF生物活性,并在大鼠卵泡条件培养基的二维凝胶中识别出GnSAF预期的等电点(pI)和分子量范围内的蛋白质,表明啮齿动物和人GnSAF蛋白之间具有良好的同源性。总之,GnSAF生物活性的释放主要来自受FSH刺激的小卵泡。因此,完整的啮齿动物卵泡培养系统为在相对生理条件下研究控制GnSAF产生的因素提供了一个极好的模型。